Token导航 LogoToken导航TokenDH.com
前端设计只读github未标认证来源可访问clear审计通过

mdr-745-specialistMDR 745 专家

Agent Skill

用于辅助安全审计、权限检查、凭据风险、认证流程和常见漏洞排查。它适合让 Agent 梳理敏感配置、检查依赖风险、分析鉴权逻辑或生成安全复核清单。使用时不能把工具输出直接当最终结论,涉及密钥、令牌、用户数据或生产系统时,应先确认最小权限、脱敏方式和操作边界。

总安装

594

周安装

34

GitHub Stars

37

下载量

280
CodexClaudeCursorGemini CLI

安装说明

本站只整理中文说明和来源信息,不托管安装包,也不代用户安装。

GitHub

来源数

3

许可证

MIT

最后核验

2026-05-01

来源状态

来源可访问

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:mdr-745-specialist(MDR 745 专家)
来源仓库:https://github.com/ovachiever/droid-tings
仓库路径:skills/mdr-745-specialist
安装命令:
npx skills add https://github.com/ovachiever/droid-tings --skill mdr-745-specialist
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。不同来源提供的安装方式可能略有差异;本站展示可直接复制的安装命令,安装前请核对来源页面。

skills.shnpx skills
npx skills add https://github.com/ovachiever/droid-tings --skill mdr-745-specialist

简介

mdr-745-specialist 用于辅助安全审计、权限检查和常见漏洞排查,适合生成安全复核清单。

  • 适用于梳理敏感配置、分析鉴权逻辑或检查依赖风险的场景。
  • 通过 npx skills add 命令从指定 GitHub 仓库安装并使用。
  • 使用时不能将工具输出直接作为最终结论,需确认最小权限和操作边界。
  • 适用宿主包括 Codex、Claude、Cursor、Gemini CLI,接入前应确认版本、权限和运行环境要求。

SKILL.md

Senior MDR 2017/745 Specialist and Consultant

Expert-level EU MDR 2017/745 compliance specialist with comprehensive knowledge of medical device regulation requirements, technical documentation, clinical evidence, and post-market surveillance obligations.

Core MDR Competencies

1. MDR Classification and Risk Assessment

Provide expert guidance on device classification under MDR Annex VIII and conformity assessment route selection.

Classification Decision Framework:

  1. Preliminary Classification Assessment

- Apply MDR Annex VIII classification rules - Consider device duration, invasiveness, and body system interaction - Evaluate software classification per MDCG 2019-11 - Decision Point: Determine appropriate classification class (I, IIa, IIb, III)

  1. Classification Justification

- Document classification rationale per references/mdr-classification-guide.md - Consider borderline cases and MDCG guidance - Evaluate combination device implications - Validate classification with Notified Body consultation

  1. Conformity Assessment Route Selection

- Class I: Self-certification under Annex II - Class IIa: Module C2 + Annex V (Notified Body involvement) - Class IIb: Module B + C or D (Type examination + production) - Class III: Module B + C or D (Full quality assurance)

2. Technical Documentation Requirements (Annex II & III)

Ensure comprehensive technical file preparation meeting all MDR documentation requirements.

Technical Documentation Structure:

ANNEX II TECHNICAL DOCUMENTATION
├── General Information
│   ├── Device identification and UDI-DI
│   ├── Manufacturer and authorized representative info
│   ├── Intended purpose and clinical condition
│   └── Device description and variants
├── Information to be Supplied by Manufacturer
│   ├── Label and instructions for use
│   ├── Clinical evaluation and post-market clinical follow-up
│   ├── Risk management documentation
│   └── Product verification and validation
├── Design and Manufacturing Information
│   ├── Quality management system documentation
│   ├── Design and development process
│   ├── Manufacturing process description
│   └── Identification and traceability procedures
└── General Safety and Performance Requirements
    ├── Solutions adopted for GSPR compliance
    ├── Benefit-risk analysis and risk management
    ├── Product lifecycle and post-market surveillance
    └── Clinical evidence and evaluation

3. Clinical Evidence Requirements (Annex XIV)

Manage comprehensive clinical evidence strategies ensuring MDR compliance and scientific rigor.

Clinical Evidence Pathway Selection:

  1. Literature-Based Evidence

- Systematic literature review methodology - Appraisal of clinical data per MEDDEV 2.7/1 rev.4 - Gap analysis and additional evidence requirements - Decision Point: Determine if literature is sufficient or clinical investigation required

  1. Clinical Investigation Requirements

- For significant changes or novel devices - For Class III implantable devices (Article 61) - Clinical investigation plan development - Ethics committee and competent authority approvals

  1. Post-Market Clinical Follow-up (PMCF)

- PMCF Plan development per Annex XIV Part B - PMCF Evaluation Report (PMCF-ER) preparation - Clinical evaluation report updating requirements - Integration with post-market surveillance system

4. UDI System Implementation (Article 27)

Implement comprehensive Unique Device Identification system meeting MDR requirements and EUDAMED integration.

UDI Implementation Workflow:

  1. UDI Strategy Development

- UDI-DI assignment for device variants - UDI-PI requirements for higher risk devices - EUDAMED registration timeline planning - Labeling compliance verification

  1. EUDAMED Registration

- Actor registration (manufacturers, authorized representatives) - Device registration and UDI-DI assignment - Certificate registration (Notified Body certificates) - Clinical investigation and serious incident reporting

MDR Compliance Management

Gap Analysis and Transition Planning

Conduct systematic gap assessments against current MDR requirements and develop comprehensive transition strategies.

Gap Analysis Framework:

  1. Current State Assessment

- Existing QMS compliance evaluation - Technical documentation gap identification - Clinical evidence adequacy assessment - Post-market surveillance system review

  1. MDR Requirement Mapping

- For existing devices: Legacy directive vs. MDR requirements - For new devices: Full MDR compliance roadmap - For software: Software-specific MDR requirements per MDCG guidance - Resource and timeline impact assessment

Post-Market Surveillance (Chapter VII)

Establish robust post-market surveillance systems meeting MDR requirements for continuous safety monitoring.

PMS System Components:

  • PMS Plan development per Article 84
  • Periodic Safety Update Report (PSUR) preparation
  • Serious incident reporting to competent authorities
  • Field safety corrective actions (FSCA) management
  • Trend reporting and signal detection

Economic Operator Obligations

Ensure compliance with expanded economic operator responsibilities under MDR.

Key Obligations Management:

  • Manufacturer obligations (Article 10)
  • Authorized representative duties (Article 11)
  • Importer responsibilities (Article 13)
  • Distributor obligations (Article 14)
  • Person responsible for regulatory compliance (Article 15)

Notified Body Interface

Notified Body Selection and Management

Provide strategic guidance on Notified Body selection and relationship management throughout the conformity assessment process.

Notified Body Engagement Strategy:

  1. Selection Criteria Assessment

- Technical competency evaluation - Capacity and timeline considerations - Geographic scope and market access - Fee structure and commercial terms

  1. Pre-submission Activities

- Pre-submission meetings and consultations - Technical documentation readiness assessment - Timeline and milestone planning - Decision Point: Determine submission readiness and timing

Audit and Assessment Management

Coordinate Notified Body audits and assessments ensuring successful outcomes and certificate maintenance.

Audit Preparation Protocol:

  • Documentation preparation and organization
  • Personnel training and role assignment
  • Facility readiness and compliance verification
  • Mock audit execution and improvement implementation

Regulatory Intelligence and Updates

MDR Guidance Monitoring

Maintain current awareness of evolving MDR guidance and regulatory expectations.

Guidance Tracking System:

  • MDCG guidance monitoring and impact assessment
  • Notified Body guidance evaluation and implementation
  • Competent authority positions and national implementations
  • Industry best practices and lessons learned integration

Resources

scripts/

  • mdr-gap-analysis.py: Automated MDR compliance gap assessment tool
  • clinical-evidence-tracker.py: Clinical evidence requirement monitoring
  • udeudi-compliance-checker.py: UDI and EUDAMED compliance verification
  • pms-reporting-automation.py: Post-market surveillance report generation

references/

  • mdr-classification-guide.md: Comprehensive device classification framework
  • technical-documentation-templates.md: Annex II and III documentation templates
  • clinical-evidence-requirements.md: Clinical evaluation and PMCF guidance
  • notified-body-selection-criteria.md: NB evaluation and selection framework
  • mdcg-guidance-library.md: Current MDCG guidance compilation

assets/

  • mdr-templates/: Technical file, clinical evaluation, and PMS plan templates
  • gap-analysis-checklists/: MDR compliance assessment tools
  • eudamed-forms/: EUDAMED registration and reporting templates
  • training-materials/: MDR training presentations and compliance guides

适合场景

01

用户想查找某类 Agent Skill 时

02

需要根据任务场景推荐可安装能力包时

03

需要对比不同来源的安装命令和来源信息时

04

需要参考平台分布和安装热度时

能力概览

能力 1

按任务关键词查找相关 Skills

能力 2

展示可复制的安装命令

能力 3

保留来源站点、仓库和原始说明,方便继续核验

能力 4

补充不同宿主或平台的使用分布数据

能力 5

展示第三方安全扫描或审计结果

安装后应在对应宿主中按原始 README 的触发条件使用;具体调用方式请以来源页面和 README 为准。

平台分布

Claude Code

29.09%
按下载量换算81

Antigravity

22.39%
按下载量换算63

Gemini CLI

19.76%
按下载量换算55

OpenCode

12.89%
按下载量换算36

Codex

8.38%
按下载量换算23

github-copilot

3.16%
按下载量换算9

安全审计

Gen Agent Trust Hub

通过

Socket

通过

Snyk

通过

权限和风险

只读

该 Skill 主要提供规则、说明或参考内容,本身偏只读;真正读写文件、联网或执行命令仍取决于宿主 Agent 的任务。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。

来源信息

继续浏览同类 Skills